Even though Agios Pharmaceuticals, Inc. ( NASDAQ:AGIO ) posted strong earnings recently, the stock hasn't reacted in ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $62.5, a high ...

The measures taken as a result of losing the deal include cutting staff, which would occur with immediate effect.

Q3 2024 Earnings Call Transcript November 5, 2024 Rhythm Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.73, expectations were $-0.8. Operator: Good day, and thank you for ...

Baron & Budd, P.C. is proud to announce its recognition by Best Law Firms for 2025. The prestigious legal guide, published by ...

*For more details about COVID-19 therapeutics and vaccines, diagnostic products and clinical trial delays, go to BioWorld Snapshots.

Bruce, Professional Relations Associate, 3M Pharmaceuticals, personal communication, March 2007). Of interest to us were the four subjects (15%) with reactions to fragrance mix. The positive ...

Third quarter net product revenues for ZORYVE® (roflumilast) franchise of $44.8M, with $22.0M for ZORYVE cream 0.3%, $20.3M for ZORYVE topical ...

Reports Q3 revenue $175.7M, consensus $157.3M. The company said, “For the third quarter and first nine months of 2024, strong performance ...

ASX swings wildly, with Quickstep and Sigma Healthcare in the spotlight, while Wall Street hits record highs following ...